Zilu Zhang

State Key Laboratory Of Medical Genomics
Shanghai, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 25 publications

CD28+ CD8+ Tem cells with a STAT1-dependent glucocorticoid receptor deficit contribute to steroid-refractory acute GVHD.

CD28+ CD8+ Tem cells with a STAT1-dependent glucocorticoid receptor deficit contribute to steroid-refractory acute GVHD.

Journal: Blood

Published: November 25, 2025

Differential Prognosis and Transplant Strategies in CBF-AML With RUNX1::RUNX1T1 Versus CBFβ::MYH11 Fusions.

Differential Prognosis and Transplant Strategies in CBF-AML With RUNX1::RUNX1T1 Versus CBFβ::MYH11 Fusions.

Journal: American journal of hematology

Published: October 05, 2025

Acute Myeloid Leukemia Patients With Myelodysplasia-Related Gene Mutations Benefit From Post-Transplant Hypomethylating Agent Maintenance.

Acute Myeloid Leukemia Patients With Myelodysplasia-Related Gene Mutations Benefit From Post-Transplant Hypomethylating Agent Maintenance.

Journal: Transplantation and cellular therapy

Published: October 03, 2025

Impacts of IPSS-M and transplant conditioning intensity in allogeneic stem cell transplant for myelodysplastic neoplasms.

Impacts of IPSS-M and transplant conditioning intensity in allogeneic stem cell transplant for myelodysplastic neoplasms.

Journal: Bone marrow transplantation

Published: September 19, 2025

Targeted next-generation sequencing for respiratory infections in patients with haematological malignancies.

Targeted next-generation sequencing for respiratory infections in patients with haematological malignancies.

Journal: Frontiers in cellular and infection microbiology

Published: August 03, 2025

Letermovir Prophylaxis Guided by Cytomegalovirus Cell-Mediated Immunity Improves the Outcomes of Allogeneic Hematopoietic Stem Cell Transplant Recipients.

Letermovir Prophylaxis Guided by Cytomegalovirus Cell-Mediated Immunity Improves the Outcomes of Allogeneic Hematopoietic Stem Cell Transplant Recipients.

Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Published: May 20, 2025

MRD and NK-Cell Chimerism Predict Transplant Outcomes in Allogeneic Hematopoietic Stem Cell Transplantation Recipients.

MRD and NK-Cell Chimerism Predict Transplant Outcomes in Allogeneic Hematopoietic Stem Cell Transplantation Recipients.

Journal: American journal of hematology

Published: February 14, 2025

Venetoclax and azacitidine compared with intensive chemotherapy for adverse-risk acute myeloid leukemia patients receiving allogeneic hematopoietic stem cell transplantation in first complete remission: A multicenter study of TROPHY group.

Venetoclax and azacitidine compared with intensive chemotherapy for adverse-risk acute myeloid leukemia patients receiving allogeneic hematopoietic stem cell transplantation in first complete remission: A multicenter study of TROPHY group.

Journal: Chinese journal of cancer research = Chung-kuo yen cheng yen chiu

Published: January 17, 2025

Targeting the RBM39-MEK5 axis synergizes with bortezomib to inhibit the malignant growth of multiple myeloma.

Targeting the RBM39-MEK5 axis synergizes with bortezomib to inhibit the malignant growth of multiple myeloma.

Journal: Blood advances

Published: January 07, 2025

Epstein-Barr virus infection following allogeneic hematopoietic stem cell transplantation in the era of letermovir for cytomegalovirus prophylaxis.

Epstein-Barr virus infection following allogeneic hematopoietic stem cell transplantation in the era of letermovir for cytomegalovirus prophylaxis.

Journal: Experimental hematology & oncology

Published: January 03, 2025

Impaired CMV-specific CD4+ T-cell reconstitution is associated with CMV infection after letermovir cessation.

Impaired CMV-specific CD4+ T-cell reconstitution is associated with CMV infection after letermovir cessation.

Journal: Experimental hematology

Published: December 01, 2024

IRF4-BLOC1S5: the first rearrangement gene identified in TEMPI syndrome.

IRF4-BLOC1S5: the first rearrangement gene identified in TEMPI syndrome.

Journal: Haematologica

Published: November 25, 2023

Showing 1-12 of 25

Last Updated: 09/26/2026